Latest in Compliance

In the news

All trending →
In the news

Berberine’s Promise for Ovarian Syndrome Crumbles Under Research Integrity Scrutiny

Bioengineer.org reports on a systematic review in Advances in Therapy, led by Eshani Perera of Western Sydney University, that assessed all four randomized trials of berberine for polycystic ovary syndrome (452 participants) using the RIGID and TRACT integrity frameworks. All four were rated high risk of compromised integrity, authors did not respond to queries, and the trials were excluded, leaving no reliable evidence to synthesise.

bioengineer.org · October 7, 2026

Coming up

Coming up

HIPAA-ready research software: what a BAA does and doesn't cover

On the publishing plan for the weeks ahead

Coming up

IRB liaisons: tracking protocols across a portfolio

On the publishing plan for the weeks ahead

Coming up

Tenant isolation and audit trails: questions to ask a vendor

On the publishing plan for the weeks ahead

Other subjects

All subjects →

AMDana

Book an AMDana demo

AMDana brings tasks, team messaging, meetings, grants, IRB, manuscripts and analysis into one collaborative workspace.